Bioiberica Obtains CSR Management System Certification Aligned with UN Sustainable Development Goals

Article

Bioiberica has received certification of its CSR management system as aligned with the United Nations Sustainable Development Goals.

Bioiberica, a global life sciences company, has received certification of its corporate social responsibility (CSR) management system as being aligned with the United Nations (UN) Sustainable Development Goals (SDGs), the company revealed in a July 27, 2021 press release.

The certification was awarded to Bioiberica after an audit process by Bureau Veritas, which highlighted strong alignment of the company’s CSR with 6 out of the 17 SDGs defined by the UN. As a result, Bioiberica has become the first Spanish pharmaceutical company to be awarded such a certification and has reaffirmed its position as committed to environmental, social, and economic sustainability.

“Bioiberica is firmly committed to sustainability and the circular economy model,” said Luis Solera, Bioiberica’s CEO, in the press release. “With this comes the responsibility of constantly working to improve the health of people, animals, and plants, and promoting a coherent ecological transition that contributes to creating a healthier planet. The recognition of the CSR management system reinforces our determination to continue working towards a better future.”

“By achieving certification of its CSR Management System aligned with the SDGs, Bioiberica takes a further step in its crucial commitment to sustainability,” added Bertrand Martin, executive president of Bureau Veritas Spain and Portugal, in the press release. “We’re very proud to have certified a company whose commitment is to improve global health and wellbeing, and working with companies like Bioiberica reinforces our desire to contribute to a more responsible economy.”

Source: Bioiberica

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content